Treatment of hyaline-membrane disease.
D002404:Catheterization; D006801:Humans; D006819:Hyaline Membrane Disease / Q000139:chemically induced* / Q000188:drug therapy* / Q000473:pathology; D007231:Infant, Newborn; D007612:Kanamycin / Q000627:therapeutic use; D010100:Oxygen / Q000009:adverse effects*; D010102:Oxygen Inhalation Therapy / Q000009:adverse effects; D014325:Tromethamine / Q000008:administration & dosage*; D014469:Umbilical Arteries; D014471:Umbilical Veins
D014325:Tromethamine; D007612:Kanamycin; D010100:Oxygen